12 results
hematology management diagnosis algorithm dosing idsa mds pharmacotherapy anemia aplastic aspergillosis autoimmune borderline bpd cancer cardiology chemotherapy copd cyp3a4 daliresp
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Antirheumatic Medication ... MithuRheum #rheumatology ... management #autoimmune #pharmacology ... #table
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines - Invasive syndromes of Aspergillus
- Invasive syndromes ... or colonizing syndromes ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic ... Syndrome (MD) - ... only curative treatment ... #Syndrome #MDS ... #hematology #oncology
Myelodysplastic Syndromes (MDS) What? Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
Myelodysplastic ... factor (GCSF) treatments ... marrow studies Treatment ... treatment (examples ... #hematology #oncology
Managing warfarin INR Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... decisionaid #cardiology #hematology
Summary of meta-analysis of pharmacotherapy trials in BPD https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... summarised in Tables ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table
Daliresp (Roflumilast) Indication: Reduce risk of COPD exacerbations Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor GOLD 2019
Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication ... #Pharmacology #
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
- Antithyroid medications ... • Hypocellular myelodysplastic ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Diuretics and Agents Regulating Renal Excretion Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide) • Glaucoma • Epilepsy • Altitude
disequilibrium syndrome ... and nephrotic syndrome ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
No results found for "Treatment guidelines medications rheumatology oncology syndrome table myelodysplastic pharmacology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Treatment #guidelines #medications #rheumatology #oncology #syndrome #table #myelodysplastic #pharmacology